Browsing Tag
Jerome D. Jabbour
1 post
Can Matinas BioPharma (MTNB) avoid delisting while trying to salvage MAT2203?
Matinas BioPharma faces NYSE American non-compliance over equity levels. Read what it means for MTNB, MAT2203, funding options, and delisting risk.